Susan L. Melvin

1.6k total citations
33 papers, 1.3k citations indexed

About

Susan L. Melvin is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, Susan L. Melvin has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 13 papers in Hematology and 9 papers in Molecular Biology. Recurrent topics in Susan L. Melvin's work include Acute Lymphoblastic Leukemia research (17 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Susan L. Melvin is often cited by papers focused on Acute Lymphoblastic Leukemia research (17 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Susan L. Melvin collaborates with scholars based in United States, United Kingdom and Canada. Susan L. Melvin's co-authors include Sanford A. Stass, SB Murphy, Joseph Mirro, T. F. Zipf, Diane L. Williams, J Mirro, CH Pui, Geoffrey R. Kitchingman, S Stass and SB Murphy and has published in prestigious journals such as Journal of Clinical Investigation, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Susan L. Melvin

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan L. Melvin United States 18 758 671 307 280 222 33 1.3k
ED Ball United States 22 911 1.2× 282 0.4× 548 1.8× 387 1.4× 219 1.0× 47 1.5k
J Tanzer France 23 595 0.8× 284 0.4× 349 1.1× 302 1.1× 446 2.0× 114 1.4k
W. D. Ludwig Germany 21 1.2k 1.5× 679 1.0× 691 2.3× 374 1.3× 291 1.3× 48 2.0k
Nahla Farahat United Kingdom 16 427 0.6× 303 0.5× 294 1.0× 413 1.5× 490 2.2× 31 1.3k
Robert Wasserman United States 18 537 0.7× 462 0.7× 545 1.8× 945 3.4× 261 1.2× 35 1.8k
Khalid Tobal United Kingdom 20 751 1.0× 282 0.4× 634 2.1× 138 0.5× 118 0.5× 40 1.3k
S Shane United States 13 409 0.5× 355 0.5× 342 1.1× 517 1.8× 251 1.1× 15 1.2k
MO Diaz United States 15 493 0.7× 300 0.4× 442 1.4× 183 0.7× 133 0.6× 22 929
F Sigaux France 23 697 0.9× 386 0.6× 515 1.7× 634 2.3× 389 1.8× 43 1.7k
Steve Kornblau United States 10 1.2k 1.5× 296 0.4× 222 0.7× 404 1.4× 253 1.1× 16 1.4k

Countries citing papers authored by Susan L. Melvin

Since Specialization
Citations

This map shows the geographic impact of Susan L. Melvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan L. Melvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan L. Melvin more than expected).

Fields of papers citing papers by Susan L. Melvin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan L. Melvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan L. Melvin. The network helps show where Susan L. Melvin may publish in the future.

Co-authorship network of co-authors of Susan L. Melvin

This figure shows the co-authorship network connecting the top 25 collaborators of Susan L. Melvin. A scholar is included among the top collaborators of Susan L. Melvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan L. Melvin. Susan L. Melvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hunt, Allison L., Mahesh Mansukhani, Claudius Mueller, et al.. (2025). Real-time functional proteomics enhances therapeutic targeting in precision oncology molecular tumor boards. npj Precision Oncology. 9(1). 111–111.
2.
Melvin, Susan L., et al.. (1998). Biophysical characterization of GB virus C from human plasma. Journal of Virological Methods. 71(2). 147–157. 9 indexed citations
3.
Gutierrez, Robin A., George J. Dawson, Mark F. Knigge, et al.. (1997). Seroprevalence of GB virus C and persistence of RNA and antibody. Journal of Medical Virology. 53(2). 167–173. 74 indexed citations
4.
Kalwinsky, David K., et al.. (1985). Periodic Acid-Schiff Stain in Childhood Acute Lymphoblastic Leukemia: Lack of Independent Prognostic Value. American Journal of Clinical Pathology. 83(4). 494–497. 1 indexed citations
5.
Mirro, Joseph, et al.. (1985). The E rosette-associated antigen of T cells can be identified on blasts from patients with acute myeloblastic leukemia. Blood. 65(2). 363–367. 52 indexed citations
6.
Melvin, Susan L., et al.. (1985). Transient myeloproliferative syndrome in a phenotypically normal infant.. PubMed. 7(1). 79–81. 27 indexed citations
7.
Kitchingman, GR, Ugo Rovigatti, AM Mauer, et al.. (1985). Rearrangement of immunoglobulin heavy chain genes in T cell acute lymphoblastic leukemia. Blood. 65(3). 725–729. 96 indexed citations
8.
Stass, S, et al.. (1984). Lineage switch in acute leukemia. Blood. 64(3). 701–706. 174 indexed citations
9.
Walker, W. S. G., et al.. (1984). Some fixation reagents reduce or abolish the detectability of Ia-antigen and HLA-DR on cells. Journal of Immunological Methods. 67(1). 89–99. 31 indexed citations
10.
Abromowitch, Minnie, Dorothy L. Williams, Susan L. Melvin, & Sanford A. Stass. (1984). Evidence for clonal evolution in pre‐B‐cell leukaemia. British Journal of Haematology. 56(3). 409–416. 8 indexed citations
11.
Look, A. Thomas, et al.. (1984). Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts.. Journal of Clinical Investigation. 73(6). 1617–1628. 31 indexed citations
12.
Stass, Sanford A., Ching‐Hon Pui, Susan L. Melvin, et al.. (1984). Sudan black B positive acute lymphoblastic leukaemia. British Journal of Haematology. 57(3). 413–421. 23 indexed citations
14.
Peiper, Stephen C., et al.. (1983). The Authors’ Reply. American Journal of Clinical Pathology. 80(4). 545–545. 1 indexed citations
15.
Bernard, Alain, SB Murphy, Susan L. Melvin, et al.. (1982). Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor. Blood. 59(3). 549–554. 52 indexed citations
16.
Melvin, Susan L.. (1981). Immunological definition of leukemic cell surface phenotypes.. PubMed. 41(11 Pt 2). 4790–3. 39 indexed citations
17.
Kalwinsky, David K., Gary V. Dahl, W. Paul Bowman, et al.. (1981). Clinical utility of initial terminal deoxynucleotidyl transferase determinations in childhood acute leukemias.. PubMed. 41(7). 2877–81. 15 indexed citations
18.
Bowman, W. Paul, Susan L. Melvin, Rhomes J. A. Aur, & Alvin M. Mauer. (1981). A clinical perspective on cell markers in acute lymphocytic leukemia.. PubMed. 41(11 Pt 2). 4794–801. 33 indexed citations
19.
Melvin, Susan L., et al.. (1980). Identification of a Leukemia-Associated Antigen of Human Acute Lymphocytic Leukemia23. JNCI Journal of the National Cancer Institute. 64(6). 1321–1328. 14 indexed citations
20.
Murphy, Sharon B., Susan L. Melvin, & Alvin M. Mauer. (1979). Correlation of tumor cell kinetic studies with surface marker results in childhood non-Hodgkin's lymphoma.. PubMed. 39(5). 1534–8. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026